CAR-scFv,BCD20

Purva Khodke1, Bajarang Vasant Kumbhar1

  • 1Department of Biological Sciences, Sunandan Divatia School of Science, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-be University, Vile Parle (West), Mumbai 400056, Maharashtra, India.

PubMed
概括

惠特洛链接器通过提高结合亲和力和稳定性来增强抗CD20化学抗原受体 (CAR) -T细胞疗法. 这种分子建模方法为下一代CAR结构提供了一个有希望的策略,该结构针对B细胞恶性瘤中的CD20.